Two government auditors will be able to cite a recent appeals court ruling to fight Shell Exploration & Production Co.'s contention that their claims involve public information that cannot be the basis of a qui tam action.
IBM Corp. and PriceWaterhouseCoopers agreed on Thursday to pay the U.S. government around $5.3 million to settle allegations that the companies provided kickbacks to government agencies for technology contracts.
A ConocoPhillips Co. subsidiary on Wednesday agreed to pay $105 million to settle the Department of Justice's claims that it “systematically” underpaid natural gas royalties it owed the federal government and Indian tribes.
An appeals court panel has affirmed the dismissal of a whistleblower suit that accused pharmacy benefits manager Caremark Rx Inc. of violating the False Claims Act.
In a bid to bring some closure to a massive antitrust class action alleging a slew of drug makers defrauded consumers by artificially inflating the prices of various prescription medications, a federal judge has ordered certain parties in the case to resolve their differences through mediation.
In a boost for TAP Pharmaceutical Products Inc., the states of Montana and Nevada have asked a federal judge to sign off on a settlement that would toss the company from a massive antitrust class action alleging that a spate of drug makers defrauded consumers by artificially inflating the prices of various prescription medications.
Government services provider Maximus Inc. has agreed to pay $30.5 million to settle a criminal investigation into the Medicaid claiming work it did for the District of Columbia.
Abbott Laboratories Inc., which stands accused of publishing inflated average wholesale prices for its drugs, won a victory Thursday when a judge acceded to its request to quash subpoenas that the federal government had served on former Abbott customers.
Abbott Laboratories, one of a slew of pharmaceutical makers involved in a massive antitrust class action alleging the companies defrauded consumers by artificially inflating the prices for various prescription drugs, has moved to dismiss fresh claims brought by government authorities.
An appeals court has blocked a former King Pharmaceuticals Inc. employee from seeking additional attorneys’ fees for his efforts in bringing a wide-scale whistleblower suit against the Bristol, Tenn.-based brand-name drug maker.
The $70 million proposed settlement with GlaxoSmithKline plc in an antitrust class action that alleged it defrauded consumers by artificially inflating the prices of various prescription drugs should be approved, the case's special settlement master concluded Monday.
The U.S. Department of Justice has intervened in a whistleblower suit against dialysis care provider Fresenius Medical Care Holdings Inc., accusing the company of defrauding Medicare for six years.
Affiliated Computer Services Inc. has reached an agreement to pay the U.S. more than $2.6 million to resolve allegations that it submitted inflated payment claims on several government contracts from 2002 to 2005.
Mellon Bank N.A. will pay more than $16 million to settle claims that its harried workers deleted more than 70,000 tax returns and checks in 2001 that the bank was supposed to process for the Internal Revenue Service.
The states of Montana and Nevada have reached a settlement with Dey Inc., one of a slew of pharmaceutical companies involved in a massive antitrust class action alleging that the companies defrauded consumers by artificially inflating the prices of various prescription drugs.
The plaintiffs in two qui tam suits accusing Pacific Lumber Co. of fraud in connection with a $390 million deal with California and the U.S. asked the court to deny the debtors' bid to halt the suits, warning that the bankrupt logging company is playing fast and loose with facts and the law.
A Japanese fiber maker has been hit with a lawsuit by the U.S. Department of Justice accusing the company of knowingly selling a defective fiber used in bullet-proof vests that weakened when exposed to florescent lights, heat and humidity.
Bankrupt timber company Pacific Lumber Co. tried on Monday to block a qui tam suit that accused the company of defrauding the state of California for over $300 million in an agreement meant to protect the environment.
A federal judge has issued a stinging rebuke to three pharmaceutical companies in a massive antitrust class action, finding that they acted unfairly and deceptively by causing the publication of artificially inflated average wholesale prices for various prescription drugs.
The plaintiffs in an antitrust class action alleging that a slew of pharmaceutical companies defrauded consumers by artificially inflating the prices of various prescription drugs have received more time to finalize a settlement with GlaxoSmithKline plc.